Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Intel Corporation (INTC) -- Ignore unavailable to you. Want to Upgrade?

To: L. Adam Latham who wrote (84034)	6/21/1999 12:49:00 AM
From: puborectalis	Read Replies (1) \| Respond to of 186894

I don't personally benefit....not everyone on these threads is motivated solely by the Almighty dollar...it just amazes me how many investors on these threads lack understanding of what has happened to their medical care...there should have been a groundswell revolt over what the managed care companies like Aetna and the Blues are doing to the QUALITY of medical care in this country.....Oh I forgot,the wealthy will always be able to afford the best of medical care. P.S.- go to Mallinckrodt for your imaging studies...excellent Dept.

To: L. Adam Latham who wrote (84034)	6/22/1999 3:44:00 AM
From: nihil	Respond to of 186894

One of the principal problems of university medical research (IMO) is that there are very few incentives for professors to discover anything, except professional pride. My university is trying to steal all intellectual property rights from the faculty. Ridiculous, there will be nothing left to steal when the productive guys pull out. Very few universities are willing to share proceeds of successful research and discovery with their faculty (who make it happen). [maybe a little summer pay!] Moreover, they do not know how to develop and commercialize their discoveries. Look at the internet and web invented in the universities which made almost nothing from the discoveries [ok, U of I's share of Spyglass). Big pharmaceuticals are in almost as bad a shape. Many of them teetering on the bring of destruction because they cannot bring out new products. When universities and drug companies discover the motivational effects of widespread bonuses and stock options, like electronics and semiconductor manufacturers, stand by for an explosion in knowledge and profitability.